Quốc gia: Bỉ
Ngôn ngữ: Tiếng Anh
Nguồn: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Diphtheria Toxoid (DT) >= 30 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/0,5 ml; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/0,5 ml; Tetanus Toxoid >= 40 IU/dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Bordetella Pertussis Pertactin 8 µg/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/0,5 ml
GlaxoSmithKline Biologicals SA-NV
J07CA02
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Suspension for injection
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Intramuscular use
Diphtheria-Pertussis-Poliomyelitis-Tetanus
CTI code: 212152-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 212152-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - FMD code: 05400571000808 - CNK code: 1552215 - Delivery mode: Medical prescription
Commercialised: Yes
2000-03-13